Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipidome alterations in human prefrontal cortex during development, aging, and cognitive disorders
Qianhui Yu, Zhisong He, Dmitry Zubkov, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 11, pp. 2952-2969
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Brain lipidomics: From functional landscape to clinical significance
Jong Hyuk Yoon, Youngsuk Seo, Yeon Suk Jo, et al.
Science Advances (2022) Vol. 8, Iss. 37
Open Access | Times Cited: 143
Oxidative stress: The nexus of obesity and cognitive dysfunction in diabetes
Huimin Li, Jing Ren, Yusi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 61
Lipidome atlas of the adult human brain
Maria Osetrova, Anna Tkachev, Waltraud Mair, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
High fat diet-induced obesity leads to depressive and anxiety-like behaviors in mice via AMPK/mTOR-mediated autophagy
Yong Li, Yujie Cheng, Yuan Zhou, et al.
Experimental Neurology (2021) Vol. 348, pp. 113949-113949
Closed Access | Times Cited: 76
Multi-omics data reveals the disturbance of glycerophospholipid metabolism caused by disordered gut microbiota in depressed mice
Tian Tian, Qiang Mao, Jing Xie, et al.
Journal of Advanced Research (2021) Vol. 39, pp. 135-145
Open Access | Times Cited: 73
Metabolomic profiling of single enlarged lysosomes
Hongying Zhu, Qianqian Li, Tiepeng Liao, et al.
Nature Methods (2021) Vol. 18, Iss. 7, pp. 788-798
Closed Access | Times Cited: 67
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 60
Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction
Fanglin Guan, Tong Ni, Weili Zhu, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 113-126
Open Access | Times Cited: 57
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Xiaojie Zhao, Siwei Zhang, Alan R. Sanders, et al.
Complex Psychiatry (2023) Vol. 9, Iss. 1-4, pp. 154-171
Open Access | Times Cited: 26
Perturbed iron biology in the prefrontal cortex of people with schizophrenia
Amit Lotan, Sandra Luza, Carlos Opazo, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 2058-2070
Open Access | Times Cited: 24
Lipidomics of Huntington’s Disease: A Comprehensive Review of Current Status and Future Directions
Ali Yilmaz, Sümeyya Akyol, Nadia Ashrafi, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 10-10
Open Access | Times Cited: 1
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Mara Dierssen, Marta Fructuoso, María Martínez de Lagrán, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 69
Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study
Yang Du, Lei Chen, Xuesong Li, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 3, pp. 615-623
Open Access | Times Cited: 64
Endocannabinoid system in psychotic and mood disorders, a review of human studies
Ranjini Garani Ramesh, Jeremy J. Watts, Romina Mizrahi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110096-110096
Open Access | Times Cited: 51
Energy metabolism in childhood neurodevelopmental disorders
Alfonso Oyarzábal, Uliana Musokhranova, Barros LF, et al.
EBioMedicine (2021) Vol. 69, pp. 103474-103474
Open Access | Times Cited: 51
Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes
Yan Zhang, Feng Liang, DuoDuo Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114046-114046
Open Access | Times Cited: 37
Impaired Membrane Lipid Homeostasis in Schizophrenia
Minghui Li, Yan Gao, Dandan Wang, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 5, pp. 1125-1135
Open Access | Times Cited: 35
Multi-omics data reveals the important role of glycerophospholipid metabolism in the crosstalk between gut and brain in depression
Jing Xie, Qi Zhong, Wen-tao Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer’s Disease
Michele Cerasuolo, Irene Di Meo, Maria Chiara Auriemma, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1362-1362
Open Access | Times Cited: 6
Metabolome signature of autism in the human prefrontal cortex
Ilia Kurochkin, Ekaterina E. Khrameeva, Anna Tkachev, et al.
Communications Biology (2019) Vol. 2, Iss. 1
Open Access | Times Cited: 48
VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction
Noriyoshi Usui, Keiko Iwata, Taishi Miyachi, et al.
EBioMedicine (2020) Vol. 58, pp. 102917-102917
Open Access | Times Cited: 40
Identification of Lipid Heterogeneity and Diversity in the Developing Human Brain
Aparna Bhaduri, Elizabeth K. Neumann, Arnold R. Kriegstein, et al.
JACS Au (2021) Vol. 1, Iss. 12, pp. 2261-2270
Open Access | Times Cited: 37
Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
Nana Li, Ping Yang, Mimi Tang, et al.
Schizophrenia (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 26
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Juan M. Godoy-Corchuelo, Luis C. Fernández-Beltrán, Zeinab Ali, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1105-1105
Open Access | Times Cited: 23
Redox imbalance and metabolic defects in the context of Alzheimer disease
Fabio Di Domenico, Chiara Lanzillotta, Marzia Perluigi
FEBS Letters (2024)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top